PMVP GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
PMV Pharmaceuticals Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
PMV Pharmaceuticals Inc
Did you know?
Capital expenditures decreased by 100% from FY24 to FY25.
Current Price
$1.43
+1.79%Profile
Valuation (TTM)
Market Cap$74.50M
P/E-0.96
EV—
P/B0.71
Shares Out52.28M
P/Sales—
Revenue$0.00
EV/EBITDA—
PMV Pharmaceuticals Inc (PMVP) Quality Analysis
PMVP Profitability
Profitability trend analysis coming soon
PMVP Growth
Growth trend analysis coming soon
PMVP Financial Health
Financial health indicators coming soon
PMVP Quality & Fundamental Analysis
PMV Pharmaceuticals Inc (PMVP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates PMV Pharmaceuticals Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
PMV Pharmaceuticals Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. and a return on equity (ROE) of -74.24%. Return on assets (ROA) stands at -66.70%.
The debt-to-equity ratio is 0.01, with a current ratio of 10.09.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether PMV Pharmaceuticals Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.